-
ProCHO® 5 Protein-free CHO Medium, NAO, Powder Kit w/o PR, 50LCatalog #: BE15-766F
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 50L powder kit (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium Powder kit, 500 LCatalog #: BE15-766L
ProCHO® 5 Protein-free CHO Medium Powder kit with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 500 L (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium NAO, Powder kit w/o PR 10 LCatalog #: BE15-766D
ProCHO® 5, protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 10 L powder kit (NAO)
Sales unit: kit -
ProCHO® 5 Protein-free CHO Medium NAO, Basal Powder, w/o PR 50 LCatalog #: WPW-045F
ProCHO® 5 Protein-free CHO Medium, basal powder, 50 L (NAO)
Sales unit: pail -
ProCHO® 5 Protein-free CHO Medium NAO, Basal Powder, w/o PR 500 LCatalog #: WPW-045L
ProCHO® 5 Protein-free CHO Medium, basal powder, 500 L (NAO)
Sales unit: pail -
ProCHO® 5 Protein-free CHO Medium, 1LCatalog #: BELN12-766Q
ProCHO® 5 protein free CHO medium, with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 1 L (NAO)
Sales unit: each -
ProCHO® 4 Protein-free CHO Medium, 1LCatalog #: 04-919Q
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L.
Sales unit: each -
ProCHO® 4 Protein-free CHO Medium, 1LCatalog #: BP04-919Q
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68, without L-glutamine, phenol red, hypoxanthine or thymidine, 1 L
Sales unit: Bottle -
Pro293TMa Serum-free Medium – Chemically Defined for 293 Adherent CellsCatalog #: BEBP12-764Q
Pro293TMa Serum-free Medium, chemically defined for adherent cells, without L-glutamine or phenol red with 0.1% Pluronic® F-68, 1 L
Sales unit: each -
Pro293s™ Serum-free Medium – Chemically Defined for 293 Cells in SuspensionCatalog #: BEBP02-025Q
Pro293sTM Serum-free Medium, chemically defined, for suspension cells, without L-glutamine, phenol red, galactose or Pluronic® F-68, 1 L
Sales unit: each
-
Cryopreservation of Peripheral Blood Mononuclear CellsDoes Not Alter Immune Cell Phenotype
-
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells
-
Two Distinct Activation Methods Yield Clinical-Scale Expansion of Peripheral Blood Derived γδ T CellsIn this study, we demonstrate that billions of γδ T cells can be generated from peripheral blood mononuclear cells (PBMCs) with two distinct activation methods, using TheraPEAK® T-VIVO® Medium.
-
Normal Peripheral Blood CD4+ T LymphocytesLonza Application Notes
-
B-ALI Immune-Airway Co-Culture Model: Normal Human Bronchial Epithelial cells and Peripheral Blood Mononuclear Cells - Instructions for useProtocol to culture B-ALI NHBE cells with PBMCs
-
Validation of Th17 Cell Differentiation from Peripheral BloodLonza White Paper
-
siRNA Transfection Protocol for Blood LymphocytesInstructions of use for transfection of human peripheral blood lympohocytes with siRNA using the Nucleofector™ Technology
-
Transfection Protocol for Human T Cells (Stim.) - HT Nucleofector™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell HT-Nucleofector™ Kit
-
Tips For Optimizing Your CD8+ T Cell and Dendritic Cell Co-culturesA co-culture between matured dendritic cells (DCs) and CD8+ T cells isolated from Lonza cryopreserved human peripheral blood mononuclear cells (PBMCs; part nos. CC-2702 – CC-2705) and we present three major takeaways from this process that are critical for successful co-culture and end-point analysis for these two cell types
-
Transfection Protocol for Human T Cells (Stim.) - 96-well Shuttle™ DeviceInstructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit